UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011152 |
|---|---|
| Receipt number | R000013048 |
| Scientific Title | Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomas |
| Date of disclosure of the study information | 2013/07/11 |
| Last modified on | 2014/05/03 12:17:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/07/09 10:50:02 | ||
| 2 | Update | 2013/07/11 17:14:52 | Anticipated trial start date |
|
| 3 | Update | 2013/07/11 17:33:44 | Recruitment status |
|
| 4 | Update | 2013/07/11 17:59:23 | Public title Acronym |
|
| 5 | Update | 2013/07/11 18:00:19 | Narrative objectives1 |
|
| 6 | Update | 2014/05/03 12:17:01 | TEL Address Address TEL |
